Amedisys (NASDAQ:AMED) Announces Quarterly Earnings Results

Amedisys (NASDAQ:AMEDGet Free Report) released its quarterly earnings data on Wednesday. The health services provider reported $1.03 EPS for the quarter, topping the consensus estimate of $1.02 by $0.01, Briefing.com reports. Amedisys had a positive return on equity of 13.00% and a negative net margin of 0.91%. The business had revenue of $571.41 million for the quarter, compared to analyst estimates of $565.38 million. During the same quarter in the prior year, the firm posted $1.00 EPS. The business’s quarterly revenue was up 2.7% compared to the same quarter last year.

Amedisys Stock Up 0.1 %

Shares of AMED opened at $91.16 on Friday. The business’s fifty day moving average price is $92.57 and its two-hundred day moving average price is $93.35. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.32. Amedisys has a 52 week low of $73.10 and a 52 week high of $96.44.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the stock. Raymond James reaffirmed a “market perform” rating on shares of Amedisys in a research note on Tuesday, March 26th. Royal Bank of Canada lifted their target price on shares of Amedisys from $97.00 to $100.00 and gave the stock an “outperform” rating in a research note on Monday, March 25th. StockNews.com initiated coverage on Amedisys in a report on Monday, April 8th. They set a “buy” rating on the stock. Finally, Cantor Fitzgerald restated a “neutral” rating and issued a $101.00 price objective on shares of Amedisys in a report on Thursday. Seven equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Amedisys currently has an average rating of “Hold” and a consensus target price of $97.50.

View Our Latest Analysis on AMED

Amedisys Company Profile

(Get Free Report)

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.

Featured Articles

Earnings History for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.